[Cefsulodin in the treatment of Pseudomonas meningitis]

Area of Science:

• Infectious Diseases
• Neurosurgery
• Pharmacology

Background:

• Pseudomonas aeruginosa is a significant cause of meningitis, particularly in neurosurgical patients or those with severe head trauma.
• Effective antibiotic treatment for P. aeruginosa meningitis requires agents that achieve adequate concentrations in the cerebrospinal fluid (CSF).

Observation:

• Three patients with P. aeruginosa meningitis were treated with cefsulodin in combination with other antibiotics.
• Two patients received intraventricular aminoglycosides alongside systemic antibiotics.
• One patient experienced recurrent meningitis despite intraventricular aminoglycoside therapy.

Findings:

• All three patients achieved a cure with cefsulodin-based regimens.
• Intraventricular cefsulodin was necessary for the definitive cure of a patient with recurrent meningitis.
• Systemic cefsulodin and amikacin cured the third patient.

Implications:

• Cefsulodin demonstrates efficacy in treating P. aeruginosa meningitis, including challenging recurrent cases.
• Intraventricular administration of cefsulodin may be a valuable strategy when systemic or other intraventricular therapies fail.
• Further investigation into CSF concentrations of cefsulodin is warranted to optimize treatment protocols.